>
Achillion Pharmaceuticals Inc logo

ACHN - Achillion Pharmaceuticals Inc Share Price

$6.76 0.0  0.0%

Last Trade - 27/01/20

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 6851
Bullish
Bearish
Unlock ACHN Revenue
Momentum
Relative Strength (%)
1m +7.30%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2013 2014 2015 2016 2017 2018 2019E 2020E CAGR / Avg
0.000 0.000 66.1 15.0 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2019,Achillion Pharmaceuticals, Inc. revenues was not reported.Net loss increased 8% to $58M. Higher net loss reflectsOutsourced research and supplies increase of 44% to $27.4M(expense), Professional and consulting fees increase of 69%to $5.4M (expense), Facilities costs increase of 29% to$1.5M (expense). Basic Earnings per Share excludingExtraordinary Items decreased from -$0.39 to -$0.42.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ACHN Revenue Unlock ACHN Revenue

Net Income

ACHN Net Income Unlock ACHN Revenue

Normalised EPS

ACHN Normalised EPS Unlock ACHN Revenue

PE Ratio Range

ACHN PE Ratio Range Unlock ACHN Revenue

Dividend Yield Range

ACHN Dividend Yield Range Unlock ACHN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
ACHN EPS Forecasts Unlock ACHN Revenue
Profile Summary

Achillion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drug therapies for infectious diseases and immune system disorders. The Company is focused on its complement inhibitor platform, directed at advancing small molecule compounds that have the potential to be used in the treatment of immune-related diseases associated with the alternative pathway of the complement system. The complement system is part of the human innate immune system. Its clinical compound from its complement inhibitor platform is ACH-4471. ACH-4471 is a potent and specific inhibitor of factor D, which demonstrated complete inhibition of the complement alternative pathway in human healthy volunteers in a Phase I clinical trial. The Company has discovered and advanced multiple compounds into clinical development, including sovaprevir, odalasvir, and ACH-3422 in its hepatitis C virus (HCV) program.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated August 5, 1998
Public Since October 26, 2006
No. of Shareholders: 58
No. of Employees: 56
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange NASDAQ Global Select Market
Shares in Issue 140,046,647
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ACHN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ACHN
Upcoming Events for ACHN
Frequently Asked Questions for Achillion Pharmaceuticals Inc
What is the Achillion Pharmaceuticals Inc share price?

As of 27/01/20, shares in Achillion Pharmaceuticals Inc are trading at $6.76, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Achillion Pharmaceuticals Inc share price performed this year?

Shares in Achillion Pharmaceuticals Inc are currently trading at $6.76 and the price has moved by 0.196k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Achillion Pharmaceuticals Inc price has moved by 0.101k% over the past year.

What are the analyst and broker recommendations for Achillion Pharmaceuticals Inc?

Of the analysts with advisory recommendations for Achillion Pharmaceuticals Inc, there are there are currently 0 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Achillion Pharmaceuticals Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Achillion Pharmaceuticals Inc next release its financial results?

Achillion Pharmaceuticals Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-09-30
What is the Achillion Pharmaceuticals Inc dividend yield?

Achillion Pharmaceuticals Inc does not currently pay a dividend.

Does Achillion Pharmaceuticals Inc pay a dividend?

Achillion Pharmaceuticals Inc does not currently pay a dividend.

When does Achillion Pharmaceuticals Inc next pay dividends?

Achillion Pharmaceuticals Inc does not currently pay a dividend.

How do I buy Achillion Pharmaceuticals Inc shares?

To buy shares in Achillion Pharmaceuticals Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Achillion Pharmaceuticals Inc?

Shares in Achillion Pharmaceuticals Inc are currently trading at $6.76, giving the company a market capitalisation of £n/a.

Where are Achillion Pharmaceuticals Inc shares listed? Where are Achillion Pharmaceuticals Inc shares listed?

Here are the trading details for Achillion Pharmaceuticals Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: ACHN
What kind of share is Achillion Pharmaceuticals Inc?

We were not able to load our ranking data for Achillion Pharmaceuticals Inc

Is there a Achillion Pharmaceuticals Inc share price forecast 2021?

We were not able to load any forecast data for Achillion Pharmaceuticals Inc.

How can I tell whether the Achillion Pharmaceuticals Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Achillion Pharmaceuticals Inc. Over the past six months, the relative strength of its shares against the market has been 27.36%. At the current price of $6.76, shares in Achillion Pharmaceuticals Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Achillion Pharmaceuticals Inc PE Ratio?

We were not able to find PE ratio data for Achillion Pharmaceuticals Inc.

Who are the key directors of Achillion Pharmaceuticals Inc?

We were unable to find the directors for Achillion Pharmaceuticals Inc.

Who are the major shareholders of Achillion Pharmaceuticals Inc?

Here are the top five shareholders of Achillion Pharmaceuticals Inc based on the size of their shareholding:

RTW Investments L.P. Investment Advisor/Hedge Fund
Percentage owned: 9.9% (13.9m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 8.76% (12.3m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 7.5% (10.5m shares)
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund
Percentage owned: 5.48% (7.67m shares)
ARP Americas LP Investment Advisor/Hedge Fund
Percentage owned: 5.06% (7.09m shares)
Similar to ACHN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.